RXRX · Recursion Pharmaceuticals, Inc.

$2.96 -0.05 (-1.66%) At close · Jul 24

Market Cap

$1.57B

529.91M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score

72/100

Short interest 34.1% of shares — P100 Days to cover 6.7 — P78 Price vs VWAP -10.7% — P28 Short-volume trend +2.4% — P51 Short interest change +4.9% — P64 Worst FTD 0.26% of shares — P85

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All

Short Interest History

Settlement Date	Current Position	Previous Position	Change	Avg Daily Volume	Days to Cover
2026-08-14 Scheduled FINRA publishes Aug 25	—	—	—	—	—
2026-07-31 Scheduled FINRA publishes Aug 11	—	—	—	—	—
2026-07-15	180,760,541	172,302,180	+8,458,361	26,882,189	6.72
2026-06-30	172,302,180	184,017,785	-11,715,605	20,547,113	8.39
2026-06-15	184,017,785	164,340,230	+19,677,555	22,006,664	8.36
2026-05-29	164,340,230	184,440,829	-20,100,599	20,501,178	8.02
2026-05-15	184,440,829	171,321,811	+13,119,018	13,889,498	13.28
2026-04-30	171,321,811	174,397,876	-3,076,065	11,590,459	14.78
2026-04-15	174,397,876	173,926,845	+471,031	10,187,971	17.12
2026-03-31	173,926,845	174,136,749	-209,904	14,147,466	12.29
2026-03-13	174,136,749	168,516,142	+5,620,607	13,739,894	12.67
2026-02-27	168,516,142	173,170,498	-4,654,356	19,015,637	8.86
2026-02-13	173,170,498	165,548,707	+7,621,791	22,708,637	7.63
2026-01-30	165,548,707	163,381,460	+2,167,247	20,828,750	7.95
2026-01-15	163,381,460	165,731,774	-2,350,314	20,049,755	8.15
2025-12-31	165,731,774	153,738,758	+11,993,016	26,991,184	6.14
2025-12-15	153,738,758	151,875,532	+1,863,226	18,710,464	8.22
2025-11-28	151,875,532	145,661,814	+6,213,718	23,432,154	6.48
2025-11-14	145,661,814	128,586,047	+17,075,767	37,489,816	3.89
2025-10-31	128,586,047	126,348,417	+2,237,630	64,709,381	1.99
2025-10-15	126,348,417	133,407,394	-7,058,977	69,403,970	1.82
2025-09-30	133,407,394	132,044,177	+1,363,217	35,928,102	3.71
2025-09-15	132,044,177	124,079,106	+7,965,071	16,730,338	7.89
2025-08-29	124,079,106	122,223,405	+1,855,701	16,288,078	7.62
2025-08-15	122,223,405	117,535,748	+4,687,657	18,598,548	6.57
2025-07-31	117,535,748	115,527,481	+2,008,267	33,007,194	3.56

Showing 1–24 of 24 settlements

Key facts CIK 1601830 CUSIP 75629V104 13F (30d) 60 filings 60 filers Visit website Investor relations